Trials / Recruiting
RecruitingNCT05224934
Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01)
Full-target Ultra-hypofractionated Stereotactic Irradiation Orchestrated With Nodule Boost for Retroperitoneal Sarcoma
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the feasibility and peri-operative complications of preoperative hypo-fractionated radiotherapy followed by surgery for retroperitoneal sarcoma
Conditions
- Soft Tissue Sarcoma
- Retroperitoneal Sarcoma
- Radiotherapy Side Effect
- Ultra-hypofractionated Radiotherapy
- Stereotactic Ablative Radiotherapy
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | ultra-hypofractionated radiotherapy | stereotactic ablative radiotherapy with 25 to 50Gy in five fractions given preoperatively |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
- First posted
- 2022-02-04
- Last updated
- 2025-12-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05224934. Inclusion in this directory is not an endorsement.